Delivery Order SPE2DB20D3505-SPE2DB24FT4C6

Award Date 11/30/23
Potential Completion Date 12/1/23
Potential Value $4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is for the delivery of 45 gram tubes of 0.2% hydrocortisone ointment, with a total ceiling value of $21,075.21. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,530.08 firm fixed-price delivery order is for the supply of 15-gram tubes of 0.2% hydrocortisone ointment. The award is not designated as a set-aside contract. The DLA IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,622.91 to AmerisourceBergen Drug Corp for the supply of 4567330281 - Hydrocortisone 1% Cream 28.4GM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,798.06 firm fixed-price delivery order is for the supply of 4,566,620,549 units of 25 mg hydrocortisone acetate suppositories. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,038,369 units of 5 mg Hydrocortisone tablets. The firm-fixed-price, $5,525.52 delivery order contract runs through January 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565334471 - Hydrocortisone 1% Cream 30GM. The contract has a firm fixed price of $3,457.69 and a period of performance through August 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566868256 - Hydrocortisone Valerate 0.2% Ointment, 60 grams. The delivery order has a ceiling value of $4,604.01 and a completion date of January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 454 gram containers of 2.5% hydrocortisone cream, with a firm fixed price of $8,066.11 and a period of performance through May 2, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $1,320.00 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply Hydrocortisone 2.5% Lotion 118ML. The contract has a completion date of January 31, 2024 and was awarded on January 30, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,142,252 units of 25mg Hydrocortisone Acetate Suppositories. The firm-fixed-price contract has a ceiling value of $1,523.56 and an ultimate completion date of December 20, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FT4C6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,976.23 firm-fixed-price delivery order is for the supply of 15 gram tubes of 0.2% hydrocortisone ointment. The award has an ultimate completion date of December 1, 2023.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery order is awarded under that IDC, which does not have a set-aside designation.

Generated 5/12/25, 9:55 AM